申请人:NodThera Limited
公开号:US11518757B2
公开(公告)日:2022-12-06
The present disclosure relates to compounds of Formula (I):
and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.
本公开涉及式(I)化合物:
及其药学上可接受的盐、药物组合物、使用方法和制备方法。本文公开的化合物可通过抑制炎性体抑制 IL-1 家族细胞因子的成熟,并可用于治疗与炎性体活性有关的疾病,如炎症、自身炎症和自身免疫性疾病及癌症。